Quarterly report pursuant to Section 13 or 15(d)

Fair Value of Financial Instruments (Tables)

v3.24.2.u1
Fair Value of Financial Instruments (Tables)
6 Months Ended
Jun. 30, 2024
Fair Value of Financial Instruments [Abstract]  
Schedule of Fair Value of Our Financial Assets and Liabilities The following table summarizes the fair value of our financial assets and liabilities that were accounted for at fair value on a recurring basis, by level within the fair value hierarchy:
    June 30, 2024  
    Level 1     Level 2     Level 3     Fair Value  
Assets:                        
Cash equivalents:                        
Money market funds     27,847      
-
     
-
      27,847  
Foreign exchange contracts receivable             17      
-
      17  
      27,847       17      
-
      28,864  
Liabilities:                                
Contingent consideration                     153       153  
Private Placement Warrants    
-
     
-
      24,887       24,887  
     
-
     
-
      25,040       25,040  
    December 31, 2023  
    Level 1     Level 2     Level 3       Fair Value  
Assets:                        
Cash equivalents:                        
Money market funds     11,377      
-
     
-
      11,377  
Foreign exchange contracts receivable             256      
-
      256  
      11,377       256      
-
      11,633  
Liabilities:                                
Contingent consideration    
-
     
-
      155       155  
     
-
     
-
      155       155  
Schedule of Fair Value Level 3 financial liabilities The changes in the fair value of the Company’s Level 3 financial liabilities, which are measured on a recurring basis are as follows:
    Six Months Ended
June 30,
2024
    Six Months Ended
June 30,
2023
 
Beginning balance    
-
     
-
 
Private Placement Warrants     28,745      
-
 
Change in fair value     (3,858 )    
-
 
Ending balance     24,887         -  
Schedule of Fair Value of the Liabilities for the Private Placement Warrants The main assumptions used are as follows:
    June 30,
2024
    December 31,
2023
 
Underlying value of Common Stock ($)     0.34      
         -
 
Exercise price ($)     0.23      
-
 
Expected volatility (%)     117.4      
-
 
Expected terms (years)     2      
-
 
Risk-free interest rate (%)     4.7      
-